{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for m root_references_url in Reference URL (approximate match)
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(20) weight control anise oil
Source URL:
First approved in 2003
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(18)(ii) skin protectant:astringent clove oil
Source URL:
First approved in 2002
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(8)(ii) digestive aid linden
Source URL:
First approved in 2001
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(24)(i) menstrual/diuretic gentiana lutea (gentian)
Source URL:
First approved in 2000
Source:
21 CFR 331
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Cimicifuga U.S.P.
(1921)
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Oil of Thyme U.S.P.
(1921)
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Spirit of Lavender U.S.P.
(1921)
Source URL:
First marketed in 1921
Source:
Spirit of Lavender U.S.P.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Juniper Berries N.F.
(1921)
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Piper methysticum (Kava) root is consumed in a wide range of Pacific Ocean societies, from coastal areas of New Guinea to Polynesian Hawaii. Kava drinking was an integral part of the religious, social, political and economic life of Pacific islands societies. Kava was also used as an important ingredient in the traditional medicine of many Pacific Islands societies. Kava beverage was regarded as having sedative activity, able to soothe the nerves, relax the mind and body, induce refreshing sleep and to ease the pain. Kava lactones have demonstrated sedative and anxiolytic activity in clinical trials. In addition to sedative activity, Western traditional indications of Kava (dried root, infusion, and aqueous ethanol extract) include infection and inflammation of the genitourinary tract, neuralgia, bronchitis, dyspepsia, dysmenorrhoea and rheumatism. A major constituent of Kava root is the resin which contains kava lactones. The major kava lactones are kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin. Other constituents include flavokavins and chalcone pigments. Extracts are often standardized for kava lactone content.